$ESLA
Estrella Immunopharma, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.452
▲After hours+1.98%+$0.009After hours
Estrella Immunopharma, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ESLA up today? It is at $0.452 (+8.21%), and our scanner flagged it 106 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ESLA spikes, and full due diligence on ESLA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ESLA 106 times in the last 30 days. Create a free account to track $ESLA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ESLA from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystExecutive / Board Change · Other Material Event, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 4, 2026 · todayAcross every filing on file, supply equal to 25.9% of the tradeable float is in play - 25.9% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
9,236,141 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Liu Cheng Officer | Other | 100K 0.2% of company | added 34% | 397K | $81K at $0.810 | Aug 25, 26 |
Xu Jiandong Officer | Other | 100K 0.2% of company | added 38% | 365K | $81K at $0.810 | Aug 18, 26 |
Xu Jiandong Officer | Bought (open market) | +1K | added 0.4% | 265K | $1K at $1.33 | Oct 7, 25 |
Xu Jiandong Officer | Bought (open market) | +1K | added 6.4% | 17K | $1K at $1.16 | Sep 22, 25 |
Xu Jiandong Officer | Bought (open market) | +100 | added <0.1% | 265K | $104 at $1.04 | Sep 11, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ESLA from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ESLA last traded at $0.452, up 8.21% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ESLA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ESLA 106 times in the last 30 days.
ESLA (Estrella Immunopharma, Inc. Common Stock) trades on XNAS, with a market cap of about $18M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ESLA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ESLA discussion
Sign in to ask a question or join the discussion.